Table of Contents Table of Contents
Previous Page  248 / 812 Next Page
Information
Show Menu
Previous Page 248 / 812 Next Page
Page Background

S244

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S116–S348

Pain and treatment options

EW374

The fibromyalgia patients would

present higher levels of magnification

that controls pain: A pilot study

K. Cabas-Hoyos

1 ,

, J.L. Mu˜noz-Salgado

2

, I. Cadavid-Perez

1

,

L. De Hoyos

1

, G. Gonzalez-Gamero

1

, L. Luna-Martinez

1

,

I. Perez-Solano

1

, L. Quintero-Soto

1

, F. Roman

3

1

Grupo CAVIDA, Facultad de Psicología, Universidad Pontificia

Bolivariana, sede Montería, Cra 6 # 97 A 99, Montería, Colombia

2

CENEM, Centro de Neurociencias Monteria, Neuropsiquiatria,

Montería, Colombia

3

Universidad Maimónides, Doctorado en Psicologia con orientación

en Neurociencia Cognitiva, Buenos Aires, Argentina

Corresponding author.

Catastrophism is a variable of great importance in the study of pain.

Catastrophism refers to a negative and exaggerated compared to

the experience of pain, both real and anticipated mental percep-

tion (Sullivan, Bishop and Pivik, 1995; Sullivan et al., 2001). The

current study to compare the levels of catastrophism in patients

with and without fibromialgia. This study is cross-cutting and com-

parative. Twenty participants (M: 47.20; SD: 12.11) distributed as

the following way:

– group 1: patients with fibromyalgia previously diagnosed

through the American College of Rheumatology criteria (

n

= 10);

– group 2: Clinical depression, defined according to the DSM-5

(

n

= 5);

– group 3: healthy patients (

n

= 5) paired by age with the group of

Fibromyalgia.

The PCS, a self-administered, was used to measure Catastrophism.

Responses were summed to yield three different subscales:

Rumination, Magnification and Helplessness. This instrument is

validated in both experimental and clinical population (Van

Damme, Crombez, Bijttebier, Gouber and Van Houdenhove, 2002;

Edwards et al., 2006). A comparison among the three groups was

established using one-way factor ANOVA. The results point out

that patients with fibromyalgia have higher levels of magnification

controls with depression and healthy group (

P

< 0.05). In contrast,

although the average level of Catastrophism total presented a

greater tendency in fibromyalgia patients no statistically signifi-

cant differences were found. This is discussed in relation to the

literature, a higher level of magnification to explain pain and main-

taining the chronicity of the disease. It is important to consider the

component catastrophism to have amultidimensional viewof pain.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.492

EW375

Women that present fibromyalgia

have higher levels in all scales of

catastrophism

K. Cabas-Hoyos

Universidad Pontificia Bolivariana, Grupo CAVIDA, Montería,

Colombia

Fibromyalgia patients value their pain as modern high and they

perceive it more as a threat than as a challenge (Ayan, 2011).

There is a relative consensus related to catastrophic thoughts that

seems to play an important role in the maintenance of chronic pain

(Esteve, Ramírez and López, 2001). The objective of the present

study was to explore the level of catastrophism in women with

and without fibromyalgia. Adult women (

n

= 39) with an average

of 47 years old (TD: 12.14) and more than 12 years schooling,

paired with healthy controls (

n

= 39) with similar characteristics.

Patients with fibromyalgia were previously diagnosed according

to ACR (American College of Rheumatology). This was a cross-

sectional study, comparative and quantitative cut. An ANOVA was

used to compare both groups. The level of catastrophismwas mea-

sured through the Pain Catastrophizing Scale (Sullivan, Bishop and

Pivick, 1995). Scale composed of 13 questions and three subscales:

rumination, magnification and hopelessness. This instrument has

been tested in both clinical and non-clinical populations (Osman

et al., 2000; Sullivan et al., 1995). Rumination, magnification and

hopelessness were trend significantly higher in the women group

with Fibromyalgia. [Rumination:

F

(1.36) = 6.22;

P

= 0.00]; [Magni-

fication:

F

(1.36) = 17.66;

P

= 0.00]; [Hopelessness:

F

(1.36) = 6.53;

P

= 0.00]. These results allowed that the total catastrophism level

was higher in the women groupwith Fibromyalgia and that the sta-

tistical significance level was reached [

F

(1.36) = 9.89;

P

= 0.00). This

type of studies will allow to study the pain as a multidimensional

entity comprised of physical, cognitive and affective aspects.

Disclosure of interest

The author has not supplied his/her decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.493

EW376

Chronic non-malignant pain (CNMP)

and substance use disorders

L. Herrera Duran

1 ,

, I. Falgas

2

, B. Cook

3

, N. Noyola

1

, M. Toro

1

,

M. Alegria

1

1

Massachusetts General Hospital, Disparities Research Unit, Boston,

USA

2

Vall d’hebrón University Hospital/Universitat Autonoma de

Barcelona, Department of Psychiatry and Forensic Medicine,

Barcelona, Spain

3

Cambridge Health Alliance and Harvard Medical School, Health

Equity Research Lab, Boston, USA

Corresponding author.

Introduction

Chronic non-malignant pain (CNMP) is defined as

pain lasting a minimum of three months. In general, chronic pain

affects 20% adult worldwide population. Moreover, pain is more

common in patients with depression, anxiety, and substance-use

disorders and with low socioeconomic status. We aimed to better

understand the influence of pain on substance use and treatment

use patterns of individuals who experienced clinically recognized

pain and have substance use disorder.

Methods

Patients with pain disturbances were identified in Elec-

tronic Health Records (EHR) through ICD-9 code 338

*

, medical

written diagnoses, or diagnoses of fibromyalgia. A patient was

considered to have a substance use disorder if he received treat-

ment for illicit drug or alcohol abuse or dependence. We combined

2010–2012 (EHR) data from primary care and specialty mental

health setting in a Boston healthcare system (

n

= 131,966 person-

years) and a specialty mental health care setting in Madrid, Spain

(

n

= 43,309 person-years).

Results

We identified that 35.3% of individualswith clinically rec-

ognized pain also report substance use disorder, compared to only

10.6% of individuals without clinically recognized pain (

P

< 0.01).

Those with co-morbid pain and substance use disorder were signif-

icantly more likely than their specialty care counterparts without

co-morbid pain and substance disorders to be seen in the emer-

gency room (56.5% vs. 36.6%, respectively,

P

< 0.01).

Conclusion

The findings suggest that CNMP is associated with an

increase risk of substance abuse disorder.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.494